The FAXP™ technology stands out in the field of spatial proteomics with its superior volume expansion capabilities. The technology can achieve a 512-fold volume increase in tissue samples while maintaining an 8-fold lateral expansion to achieve a lateral resolution of 125 microns. This remarkable volume expansion capability not only greatly improves the quantity and quality of protein identifications, but compared to other spatial proteomics technologies, the FAXP technology also excels in time efficiency compared to other technologies, reducing time consumption by 50%+. These characteristics make the FAXP technology a clear advantage in the research of precision medicine and disease diagnosis.
Decoding the Microcosm of Life, Advancing Human Health for All
WESTLAKE OMICS
Established in July 2020, Westlake Omics is a micro-world data company empowered by Al. Its primary goal is to enhance precision medicine and facilitate drug research and development by leveraging technological innovations in proteomics and multimodal big data technology.
Westlake Omics has partnered with more than 100 prestigious universities, research institutes, hospitals, and pharmaceutical companies both domestically and internationally. Additionally, it holds ownership of multiple national patents and software copyrights.
PRODUCTS
Honors & Awards
